Related Experiment Video
Updated: May 1, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk
Assi Milwidsky1, Shaye Kivity2, Eran Kopel3
1Leviev Heart Center, Sheba Medical Center, Israel; Department of Internal Medicine "E", Tel-Aviv Medical Center, Israel.
Insights
Persistently low high-density lipoprotein cholesterol (HDL-C) significantly increases cardiovascular event risk. Maintaining high HDL-C levels, even if intermittent, is associated with lower cardiovascular risk.
Area of Science:
- Cardiology
- Lipid Metabolism
- Preventive Medicine
Background:
- High-density lipoprotein cholesterol (HDL-C) is a key inverse predictor of cardiovascular events.
- Understanding HDL-C dynamics is crucial for cardiovascular risk assessment.
Purpose of the Study:
- To investigate the association between changes in HDL-C levels and the occurrence of subsequent cardiovascular events.
- To determine if persistently low HDL-C impacts cardiovascular risk differently than fluctuating levels.
Main Methods:
- Analysis of 13,037 cardiovascular disease-free subjects with a 6-year follow-up.
- Classification into persistently-low (LL), persistently-high (HH), and intermittently high (LH/HL) HDL-C groups.
- Primary endpoint: first occurrence of a cardiovascular event, analyzed using Kaplan-Meier and Cox regression.
Main Results:
- A total of 529 incident cardiovascular events were recorded.
- Persistently low HDL-C was associated with a 51% increased cardiovascular risk compared to persistently high HDL-C.
- Intermittently high HDL-C groups showed similar cardiovascular risk to persistently high HDL-C groups.
Conclusions:
- Variations in HDL-C levels over time are significantly linked to future cardiovascular risk.
- Patients consistently maintaining low HDL-C levels face the highest cardiovascular risk.
Background:
High-density lipoprotein cholesterol (HDL-C) is a strong inverse predictor of cardiovascular events. The aim of the current study was to evaluate the correlation between changes in HDL-C and subsequent cardiovascular events.
Methods:
Study population comprised 13,037 subjects free of cardiovascular disease with a mean follow up of 6 ± 3 years. Low HDL-C was defined as < 40 mg/dl for men and <50mg/dl for women. Participants were divided into three groups based on HDL-C levels at the first and second baseline visits: persistently-low HDL-C (LL); persistently-high HDL-C (HH); and those with high HDL-C in a one visit only: intermittently high HDL-C (LH/HL). The primary endpoint was the first occurrence of a cardiovascular event.
Results:
A total of 529 (4.1%) incident events occurred during follow-up. HDL-C levels increased significantly between the two landmark visits (47.5 ± 12.6 vs. 48.1 ± 12.2, p<0.001). Kaplan-Meier survival analysis showed that the cumulative probability of cardiovascular events at 6 years was highest among subjects in the LL group (7.6%), and similar among LH/HL and HH groups (3.3% and 4%, respectively; log-rank p=0.001). Multivariate Cox regression analysis, with HDL-C as time-dependent covariate, showed that subjects with persistently low HDL-C during follow up experienced a 51% increased cardiovascular risk compared with subjects with persistently high HDL-C (p=0.026). Subjects with intermittently high HDL-C during follow up experienced similar risk to those with persistently high HDL-C (HR=1.02; p=0.89).
Conclusions:
Variations in HDL-C levels during follow-up are associated with subsequent cardiovascular risk. Patients who retain low HDL-C levels are at the cardiovascular highest risk.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...

